Sessions

21 – A New Era of Pharma Collaboration: Pharma’s Evolution from Products to Outcomes

The digital transformation of pharma is accelerating a change in business models, shifting the focus from products to outcomes. This value-based approach to medicine means radical changes for the centuries old industry as it adapts to changing regulations, payment structures and data access. This session with one of the first Chief Digital Officers in the pharmaceutical industry will explain the changes in the industry, and the promise it holds for improving both research, patient care, and deeper collaboration with providers and payers.